Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cantel Medical Corp (NYSE:CMN)

77.98
Delayed Data
As of Sep 30
 +0.78 / +1.01%
Today’s Change
52.23
Today|||52-Week Range
81.63
+25.49%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$3.2B

Company Description

Cantel Medical Corp. engages in the research, development, and manufacture of infection prevention, equipment, and control products. It operates through the following segments: Endoscopy; Water Purification and Filtration; Healthcare Disposables; and Dialysis. The Endoscopy segment produces medical device reprocessing systems, disinfectants, and detergents to disinfect endoscopes and reusable components. The Water Purification and Filtration segment provides purification equipment, separation, sterilization, and decontamination products. The Healthcare Disposables segment manufactures face masks, sterilization pouches, towels, bibs, tray covers, saliva ejectors, germicidal wipes, and filter system for dental unit waterlines. The Dialysis segment develops and markets medical device reprocessing systems, sterilants, disinfectants, dialysate concentrates, and supplies. The company was founded on August 16, 1963 and is headquartered in Little Falls, NJ.

Contact Information

Cantel Medical Corp.
150 Clove Road
Little Falls New Jersey 07424-2139
P:(973) 890-7220
Investor Relations:

Employees

Shareholders

Mutual fund holders44.73%
Other institutional39.05%
Individual stakeholders18.49%

Top Executives

Jorgen B. HansenPresident, CEO, COO & Director
Peter G. CliffordChief Financial Officer & Executive Vice President
Lawrence ConwayVice President-Information Systems & Procurement
James M. WilsonChief Compliance Officer
Eric W. NodiffSecretary, Executive VP & General Counsel